Log in
Enquire now
‌

US Patent 10980793 Methods of treating cancer with farnesyltransferase inhibitors

Patent 10980793 was granted and assigned to Kura Oncology, Inc. on April, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Kura Oncology, Inc.
Kura Oncology, Inc.
Current Assignee
Kura Oncology, Inc.
Kura Oncology, Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10980793
Date of Patent
April 20, 2021
Patent Application Number
16541063
Date Filed
August 14, 2019
Patent Citations
‌
US Patent 10426767 Methods of treating cancer with farnesyltransferase inhibitors
‌
US Patent 10137121 Methods of treating cancer with farnesyltransferase inhibitors
Patent Citations Received
‌
US Patent 11541045 Methods of treating cancer with farnesyltransferase inhibitors
Patent Primary Examiner
‌
Yevgeny Valenrod
Patent abstract

The present invention relates to the field of cancer therapy. Specifically, provided are methods of treating cancer, for example, peripheral T-cell lymphoma (“PTCL”), with a farnesyltransferase inhibitor (FTI) that include determining whether the subject is likely to be responsive to the FTI treatment based on gene expression characteristics.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10980793 Methods of treating cancer with farnesyltransferase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.